ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
68.080,43
0,52%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Pharmaceutical Companies (PRX)

  7. Pharmaceutical Companies (PRX) News

PRX

Pharmacutical (PRX)

Pharmaceutical Companies
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:PRX
DatumZeitQuelleÜberschriftSymbolFirma
10/08/201515h10Dow Jones NewsEndo International Beats Revenue, Earnings TargetsNYSE:PRXPharmaceutical Companies
26/05/201516h19PR Newswire (US)Par Specialty Pharmaceuticals Launches Cortisporin®-TC Otic SuspensionNYSE:PRXPharmaceutical Companies
18/05/201522h09Dow Jones NewsStocks Gain; Dow, S&P 500 Flirt With RecordsNYSE:PRXPharmaceutical Companies
18/05/201519h50Dow Jones NewsStocks Gain; Dow, S&P 500 Flirt With RecordsNYSE:PRXPharmaceutical Companies
18/05/201518h18Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 4th UpdateNYSE:PRXPharmaceutical Companies
18/05/201517h53Dow Jones NewsU.S. Stocks Waver After Dow Touches RecordNYSE:PRXPharmaceutical Companies
18/05/201517h05Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd UpdateNYSE:PRXPharmaceutical Companies
18/05/201516h37Dow Jones NewsU.S. Stocks Edge Higher; Dow Hits RecordNYSE:PRXPharmaceutical Companies
18/05/201515h20Dow Jones NewsEndo to Buy Par PharmaNYSE:PRXPharmaceutical Companies
18/05/201514h53Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd UpdateNYSE:PRXPharmaceutical Companies
18/05/201514h50Dow Jones NewsU.S. Stock Futures Edge LowerNYSE:PRXPharmaceutical Companies
18/05/201513h44Dow Jones NewsEndo to Buy Generics Maker Par Pharma for About $8 Billion -- UpdateNYSE:PRXPharmaceutical Companies
18/03/201421h32Edgar (US Regulatory)Annual Report (10-k)NYSE:PRXPharmaceutical Companies
20/02/201420h45Edgar (US Regulatory)Current Report Filing (8-k)NYSE:PRXPharmaceutical Companies
19/02/201421h08Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)NYSE:PRXPharmaceutical Companies
19/02/201421h03Edgar (US Regulatory)Current Report Filing (8-k)NYSE:PRXPharmaceutical Companies
12/11/201314h06Edgar (US Regulatory)Quarterly Report (10-q)NYSE:PRXPharmaceutical Companies
28/08/201312h01Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:PRXPharmaceutical Companies
28/08/201312h01Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:PRXPharmaceutical Companies
27/08/201317h36Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)NYSE:PRXPharmaceutical Companies
27/08/201317h36Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:PRXPharmaceutical Companies
15/08/201314h13Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NYSE:PRXPharmaceutical Companies
11/02/201317h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:PRXPharmaceutical Companies
16/10/201214h58Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NYSE:PRXPharmaceutical Companies
12/10/201214h30Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NYSE:PRXPharmaceutical Companies
10/10/201216h59Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NYSE:PRXPharmaceutical Companies
09/10/201217h03Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
09/10/201217h02Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
09/10/201217h01Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
09/10/201217h00Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
 Showing the most relevant articles for your search:NYSE:PRX

Kürzlich von Ihnen besucht

USOTC
RHHBY
Roche (QX)
FX
EURUSD
Euro vs US Dollar
CCOM
US500
US 500
AMEX
SPY
SPDR S&P 500
AMEX
XLF
Financial Select Sector
NASDAQ
AAPL
Apple
USOTC
BASFY
BASF (QX)
TG
CBK
Commerzbank
TG
DTE
Deutsche Telekom
AMEX
XLV
Health Care Select Sector
FX
EURGBP
Euro vs Sterling
NYSE
NKE
Nike
NYSE
KO
Coca Cola
AMEX
XLE
Energy Select Sector SPDR
DBI
TDXP
Tec DAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten